CancerIQ is a technology-driven company focused on enhancing access to precision cancer prevention, early detection, and treatment through innovative software and services. Their platform leverages genetic information to improve cancer care at scale, significantly increasing genetic counseling capacity and testing uptake. With over $26 million raised, including support from major investors like Merck Global Health Innovation Fund and Amgen Ventures, CancerIQ is committed to expanding its network of clinical locations and partnerships in the diagnostic and genomics sectors. The company seeks passionate individuals to join their mission-driven team, dedicated to making a meaningful impact on patient outcomes in the fight against cancer.